FDA Inspection 1244417 — Vasundhara Cheekati
The FDA completed an inspection of Vasundhara Cheekati on Jun 21, 2024 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 21, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Atlanta, GA (United States)
Additional Details
Clinical Investigator (CI)